Looking at 'cost' and 'value' under different evaluation processes
Daniel Liden, Context Matters
Advertisement
Articles by Daniel Liden, Context Matters
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Roundtable: Patient Services Leaders on the Pressures Shaping Hubs in 2026
2
Roundtable: The State of Hub Services in 2026
3
What the USMCA Joint Review Means for Pharma
4
Payers Want Real-World Evidence. Why Aren't They Using It?
5